Quotes 5-day view Delayed Nasdaq Copenhagen
06/29/2022
06/30/2022
07/01/2022
07/04/2022
07/05/2022
Date
523(c)
516.6(c)
525.4(c)
529.6(c)
535(c)
Last
176 722
195 955
157 458
130 783
252 907
Volume
-0.11%
-1.22%
+1.70%
+0.80%
+1.02%
Change
Estimated financial data (e) EUR USD
Sales 2022
1 212 M
1 242 M
1 242 M
Net income 2022
231 M
237 M
237 M
Net Debt 2022
888 M
910 M
910 M
P/E ratio 2022
41,0x
Yield 2022
1,32%
Sales 2023
1 315 M
1 347 M
1 347 M
Net income 2023
264 M
271 M
271 M
Net Debt 2023
854 M
875 M
875 M
P/E ratio 2023
35,9x
Yield 2023
1,47%
Capitalization
9 467 M
9 699 M
9 699 M
EV / Sales 2022
8,54x
EV / Sales 2023
7,85x
Nbr of Employees
3 702
Free-Float
77,8%
Chr. Hansen Holding A/S specializes in the development, production and marketing of biotechnological ingredients for the food processing, animal feed and health industries. Net sales (excluding activities being sold) break down by family of products as follows:
- cultivations and enzymes (65%);
- medical and nutritional ingredients (35%): used in the manufacturing of dietary supplements, OTC drugs, baby products...
Ratings of Chr. Hansen Holding A/S
All news about CHR. HANSEN HOLDING A/S
News in other languages on CHR. HANSEN HOLDING A/S
Analyst Recommendations on CHR. HANSEN HOLDING A/S
Chart CHR. HANSEN HOLDING A/S
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CHR. HANSEN HOLDING A/S
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
71,90 €
Average target price
72,82 €
Spread / Average Target
1,28%
Please enable JavaScript in your browser's settings to use dynamic charts.